Iovance Biotherapeutics (IOVA) Short Interest Ratio & Short Volume → Have You Seen Elon’s New A.I. Device? (Picture Inside) (From InvestorPlace) (Ad) Free IOVA Stock Alerts $11.95 +0.17 (+1.44%) (As of 09:53 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Iovance Biotherapeutics Short Interest DataCurrent Short Volume48,980,000 sharesPrevious Short Volume46,380,000 sharesChange Vs. Previous Month+5.61%Dollar Volume Sold Short$582.37 millionShort Interest Ratio / Days to Cover5.5Last Record DateApril 15, 2024Outstanding Shares279,310,000 sharesFloat Size220,710,000 sharesShort Percent of Float22.19%Today's Trading Volume577,187 sharesAverage Trading Volume8,221,415 sharesToday's Volume Vs. Average7% Short Selling Iovance Biotherapeutics ? Sign up to receive the latest short interest report for Iovance Biotherapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIOVA Short Interest Over TimeIOVA Days to Cover Over TimeIOVA Percentage of Float Shorted Over Time Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide Iovance Biotherapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202448,980,000 shares $582.37 million +5.6%22.2%5.5 $11.89 3/31/202446,380,000 shares $687.35 million -2.2%21.1%4.9 $14.82 3/15/202447,430,000 shares $659.75 million +1.5%21.6%4.6 $13.91 2/29/202446,710,000 shares $743.16 million +8.7%21.2%4.5 $15.91 2/15/202442,980,000 shares $424.21 million +2.4%20.1%4.4 $9.87 1/31/202441,970,000 shares $324.43 million -3.0%21.0%5.6 $7.73 Get the Latest News and Ratings for IOVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iovance Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202443,270,000 shares $389.86 million +18.8%21.7%5.7 $9.01 12/31/202336,410,000 shares $296.01 million +3.2%18.2%4.8 $8.13 12/15/202335,280,000 shares $274.48 million +2.0%17.7%5.1 $7.78 11/30/202334,590,000 shares $209.96 million -2.8%17.5%4.7 $6.07 11/15/202335,590,000 shares $169.05 million -8.4%18.0%5.2 $4.75 10/31/202338,860,000 shares $148.45 million +0.3%19.4%6 $3.82 10/15/202338,740,000 shares $140.63 million +5.4%19.4%6.4 $3.63 9/30/202336,770,000 shares $167.30 million +20.5%18.4%6 $4.55 9/15/202330,510,000 shares $160.79 million +1.5%15.3%4.9 $5.27 8/31/202330,070,000 shares $181.62 million +9.2%14.7%6.2 $6.04 8/15/202327,530,000 shares $206.75 million -0.1%13.5%4.6 $7.51 7/31/202327,550,000 shares $200.01 million +6.1%13.6%4.6 $7.26 7/15/202325,960,000 shares $201.45 million -10.1%13.1%4.4 $7.76 6/30/202328,890,000 shares $203.39 million +12.8%14.6%5.1 $7.04 6/15/202325,620,000 shares $221.36 million +18.3%14.1%4.8 $8.64 5/31/202321,650,000 shares $189.22 million -7.4%11.9%4.4 $8.74 5/15/202323,380,000 shares $183.30 million No Change12.9%5.9 $7.84 10/31/202217,260,000 shares $161.21 million -5.0%12.2%8 $9.34 10/15/202218,170,000 shares $160.80 million -2.6%12.7%8.2 $8.85 9/30/202218,660,000 shares $178.76 million -4.5%13.0%8 $9.58 9/15/202219,540,000 shares $231.94 million -0.6%13.7%6.5 $11.87 8/31/202219,650,000 shares $210.65 million -5.4%13.7%5.6 $10.72 8/15/202220,760,000 shares $266.77 million +6.9%14.5%4.1 $12.85 7/31/202219,420,000 shares $226.24 million -2.6%14.0%3.8 $11.65 7/15/202219,940,000 shares $255.23 million -7.5%14.3%4.1 $12.80 6/30/202221,550,000 shares $237.91 million +30.1%15.5%4.4 $11.04 6/15/202216,560,000 shares $135.79 million -4.7%11.9%3.5 $8.20 5/31/202217,370,000 shares $117.25 million +1.0%12.5%4.6 $6.75 5/15/202217,200,000 shares $242.00 million +8.8%12.4%8.2 $14.07 4/30/202215,810,000 shares $239.52 million +3.7%11.4%7.7 $15.15 4/15/202215,250,000 shares $268.71 million +9.9%11.0%7.3 $17.62 3/31/202213,880,000 shares $231.10 million +1.5%N/A6.3 $16.65 3/15/202213,680,000 shares $171.14 million -0.3%9.9%6.7 $12.51 2/28/202213,720,000 shares $214.99 million +9.4%10.1%7 $15.67Have You Seen Elon’s New A.I. Device? (Picture Inside) (Ad)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...This strange new device to protect us against that A.I. threat... IOVA Short Interest - Frequently Asked Questions What is Iovance Biotherapeutics' current short interest? Short interest is the volume of Iovance Biotherapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 48,980,000 shares of IOVA short. 22.19% of Iovance Biotherapeutics' shares are currently sold short. Learn More on Iovance Biotherapeutics' current short interest. What is a good short interest ratio for Iovance Biotherapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IOVA shares currently have a short interest ratio of 6.0. Learn More on Iovance Biotherapeutics's short interest ratio. Which institutional investors are shorting Iovance Biotherapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Iovance Biotherapeutics: Simplex Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Iovance Biotherapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.19% of Iovance Biotherapeutics' floating shares are currently sold short. Is Iovance Biotherapeutics' short interest increasing or decreasing? Iovance Biotherapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 48,980,000 shares, an increase of 5.6% from the previous total of 46,380,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Iovance Biotherapeutics' float size? Iovance Biotherapeutics currently has issued a total of 279,310,000 shares. Some of Iovance Biotherapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Iovance Biotherapeutics currently has a public float of 220,710,000 shares. How does Iovance Biotherapeutics' short interest compare to its competitors? 22.19% of Iovance Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Iovance Biotherapeutics: SpringWorks Therapeutics, Inc. (14.28%), Apogee Therapeutics, Inc. (12.97%), ImmunityBio, Inc. (40.05%), Arcellx, Inc. (10.13%), Immunocore Holdings plc (8.38%), Immunovant, Inc. (14.08%), Denali Therapeutics Inc. (8.33%), Vericel Co. (9.36%), Kymera Therapeutics, Inc. (15.81%), Krystal Biotech, Inc. (8.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Iovance Biotherapeutics stock? Short selling IOVA is an investing strategy that aims to generate trading profit from Iovance Biotherapeutics as its price is falling. IOVA shares are trading down $0.25 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Iovance Biotherapeutics? A short squeeze for Iovance Biotherapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IOVA, which in turn drives the price of the stock up even further. How often is Iovance Biotherapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IOVA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: SWTX Short Interest APGE Short Interest IBRX Short Interest ACLX Short Interest IMCR Short Interest IMVT Short Interest DNLI Short Interest VCEL Short Interest KYMR Short Interest KRYS Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IOVA) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersElon’s New A.I. Device is About to Shock the WorldInvestorPlaceAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders😱 This phenomenon is smashing regular market gainsMillPub#1 election stockPorter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldDollar CancelledLear Capital